Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT05244343
  4. Details
NCT05244343 Clinical Trial

I VACCIN Hospitalization of COVID-19 Patients

COVID-19 Clinical Trial

Official title:
Impact of Vaccination on Medical and Intensive Care Hospitalization of COVID-19 Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05244343
Other study ID # I VACCIN
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 25, 2022
Est. completion date March 10, 2022

Study information
Verified date March 2022
Source Eshmoun Clinical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A REALLIFE evaluation of rate of hospitalized patients in Intensive Care Units and in medical Units of non -vaccinated patients vs vaccinated patients

Description:

Transversal National multicenter non interventional on the COVID-19 vaccines - Period of hospitalization: from January 1st to March 3rd, 2022 - Recruitment duration: 37 days - Total study duration: 44 days

Recruitment information / eligibility
Status Completed
Enrollment 1096
Est. completion date March 10, 2022
Est. primary completion date March 3, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male and Female = 18 years - Confirmed COVID-19 patients hospitalized in ICU and Medical Units during the period of the study from January 1st to March 3rd. Exclusion Criteria: - Subjects vaccinated outside Tunisia - Subjects <18 years - Not confirmed COVID-19 - Not hospitalized patients

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Tunisia Abderrahmen Mami Hospital Ariana

Sponsors (1)
Lead Sponsor Collaborator
Eshmoun Clinical Research Center

Country where clinical trial is conducted

Tunisia, 

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of COVID-19 not vaccinated patients hospitalized in ICU Rate of non vaccinated patients who were hospitalized in ICU due to COVID-19 compared to all patients hospitalized due to COVID-19 From January 1st to February 15th
Primary Rate of COVID-19 not fully vaccinated patients hospitalized in ICU Rate of not fully vaccinated patients who were hospitalized in ICU due to COVID-19 compared to the total number of Hospitalized patients From January 1st to February 15th
Secondary Rate of COVID-19 not vaccinated patients hospitalized in Medical Units Rate of non vaccinated patients who were hospitalized in Medical units due to COVID-19 compared to all patients hospitalized due to COVID-19 From January 1st to February 15th
Secondary Rate of COVID-19 not fully vaccinated patients hospitalized in Medical Units Rate of not fully vaccinated patients who were hospitalized in Medical units due to COVID-19 compared to all patients hospitalized due to COVID-19 From January 1st to February 15th
Secondary Rate of COVID-19 vaccinated patients hospitalized in Medical Unit by type of vaccine Rate of COVID-19 vaccinated patients hospitalized in Medical Unit by type of vaccine received From January 1st to February 15th
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure